Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27


Chemotherapy enriches for an invasive triple-negative breast tumor cell subpopulation expressing a precursor form of N-cadherin on the cell surface.

Nelson ER, Li S, Kennedy M, Payne S, Kilibarda K, Groth J, Bowie M, Parilla-Castellar E, de Ridder G, Marcom PK, Lyes M, Peterson BL, Cook M, Pizzo SV, McDonnell DP, Bachelder RE.

Oncotarget. 2016 Dec 20;7(51):84030-84042. doi: 10.18632/oncotarget.12767.


Ascites Increases Expression/Function of Multidrug Resistance Proteins in Ovarian Cancer Cells.

Mo L, Pospichalova V, Huang Z, Murphy SK, Payne S, Wang F, Kennedy M, Cianciolo GJ, Bryja V, Pizzo SV, Bachelder RE.

PLoS One. 2015 Jul 6;10(7):e0131579. doi: 10.1371/journal.pone.0131579. eCollection 2015.


Nuclear basic fibroblast growth factor regulates triple-negative breast cancer chemo-resistance.

Li S, Payne S, Wang F, Claus P, Su Z, Groth J, Geradts J, de Ridder G, Alvarez R, Marcom PK, Pizzo SV, Bachelder RE.

Breast Cancer Res. 2015 Jul 4;17:91. doi: 10.1186/s13058-015-0590-3.


Syngeneic Murine Ovarian Cancer Model Reveals That Ascites Enriches for Ovarian Cancer Stem-Like Cells Expressing Membrane GRP78.

Mo L, Bachelder RE, Kennedy M, Chen PH, Chi JT, Berchuck A, Cianciolo G, Pizzo SV.

Mol Cancer Ther. 2015 Mar;14(3):747-56. doi: 10.1158/1535-7163.MCT-14-0579. Epub 2015 Jan 14.


Model of tumor dormancy/recurrence after short-term chemotherapy.

Li S, Kennedy M, Payne S, Kennedy K, Seewaldt VL, Pizzo SV, Bachelder RE.

PLoS One. 2014 May 20;9(5):e98021. doi: 10.1371/journal.pone.0098021. eCollection 2014.


Evidence for phenotypic plasticity in aggressive triple-negative breast cancer: human biology is recapitulated by a novel model system.

D'Amato NC, Ostrander JH, Bowie ML, Sistrunk C, Borowsky A, Cardiff RD, Bell K, Young LJ, Simin K, Bachelder RE, Delrow J, Dawson A, Yee LD, Mrózek K, Clay TM, Osada T, Seewaldt VL.

PLoS One. 2012;7(9):e45684. doi: 10.1371/journal.pone.0045684. Epub 2012 Sep 25.


Nuclear Snail1 and nuclear ZEB1 protein expression in invasive and intraductal human breast carcinomas.

Geradts J, de Herreros AG, Su Z, Burchette J, Broadwater G, Bachelder RE.

Hum Pathol. 2011 Aug;42(8):1125-31. doi: 10.1016/j.humpath.2010.11.004. Epub 2011 Feb 11. Erratum in: Hum Pathol. 2012 Oct;43(10):1787.


Autocrine Semaphorin3A stimulates eukaryotic initiation factor 4E-dependent RhoA translation in breast tumor cells.

Pan H, Bachelder RE.

Exp Cell Res. 2010 Oct 15;316(17):2825-32. doi: 10.1016/j.yexcr.2010.07.012. Epub 2010 Jul 22.


Autocrine semaphorin3A stimulates alpha2 beta1 integrin expression/function in breast tumor cells.

Pan H, Wanami LS, Dissanayake TR, Bachelder RE.

Breast Cancer Res Treat. 2009 Nov;118(1):197-205. doi: 10.1007/s10549-008-0179-y. Epub 2008 Sep 12.


Vascular endothelial growth factor-A stimulates Snail expression in breast tumor cells: implications for tumor progression.

Wanami LS, Chen HY, Peiró S, García de Herreros A, Bachelder RE.

Exp Cell Res. 2008 Aug 1;314(13):2448-53. doi: 10.1016/j.yexcr.2008.05.004. Epub 2008 May 17.


The alpha6beta4 integrin can regulate ErbB-3 expression: implications for alpha6beta4 signaling and function.

Folgiero V, Bachelder RE, Bon G, Sacchi A, Falcioni R, Mercurio AM.

Cancer Res. 2007 Feb 15;67(4):1645-52.


Non-angiogenic functions of VEGF in breast cancer.

Mercurio AM, Lipscomb EA, Bachelder RE.

J Mammary Gland Biol Neoplasia. 2005 Oct;10(4):283-90. Review.


Glycogen synthase kinase-3 is an endogenous inhibitor of Snail transcription: implications for the epithelial-mesenchymal transition.

Bachelder RE, Yoon SO, Franci C, de Herreros AG, Mercurio AM.

J Cell Biol. 2005 Jan 3;168(1):29-33.


Autocrine signaling in carcinoma: VEGF and the alpha6beta4 integrin.

Mercurio AM, Bachelder RE, Bates RC, Chung J.

Semin Cancer Biol. 2004 Apr;14(2):115-22. Review.


Flt-1-dependent survival characterizes the epithelial-mesenchymal transition of colonic organoids.

Bates RC, Goldsmith JD, Bachelder RE, Brown C, Shibuya M, Oettgen P, Mercurio AM.

Curr Biol. 2003 Sep 30;13(19):1721-7.


Competing autocrine pathways involving alternative neuropilin-1 ligands regulate chemotaxis of carcinoma cells.

Bachelder RE, Lipscomb EA, Lin X, Wendt MA, Chadborn NH, Eickholt BJ, Mercurio AM.

Cancer Res. 2003 Sep 1;63(17):5230-3.


Integrin (alpha 6 beta 4) regulation of eIF-4E activity and VEGF translation: a survival mechanism for carcinoma cells.

Chung J, Bachelder RE, Lipscomb EA, Shaw LM, Mercurio AM.

J Cell Biol. 2002 Jul 8;158(1):165-74. Epub 2002 Jul 8.


Integrin laminin receptors and breast carcinoma progression.

Mercurio AM, Bachelder RE, Chung J, O'Connor KL, Rabinovitz I, Shaw LM, Tani T.

J Mammary Gland Biol Neoplasia. 2001 Jul;6(3):299-309. Review.


Vascular endothelial growth factor is an autocrine survival factor for neuropilin-expressing breast carcinoma cells.

Bachelder RE, Crago A, Chung J, Wendt MA, Shaw LM, Robinson G, Mercurio AM.

Cancer Res. 2001 Aug 1;61(15):5736-40.


The cleavage of Akt/protein kinase B by death receptor signaling is an important event in detachment-induced apoptosis.

Bachelder RE, Wendt MA, Fujita N, Tsuruo T, Mercurio AM.

J Biol Chem. 2001 Sep 14;276(37):34702-7. Epub 2001 Jul 19.


The metastatic odyssey: the integrin connection.

Mercurio AM, Bachelder RE, Rabinovitz I, O'Connor KL, Tani T, Shaw LM.

Surg Oncol Clin N Am. 2001 Apr;10(2):313-28, viii-ix. Review.


p53 inhibits alpha 6 beta 4 integrin survival signaling by promoting the caspase 3-dependent cleavage of AKT/PKB.

Bachelder RE, Ribick MJ, Marchetti A, Falcioni R, Soddu S, Davis KR, Mercurio AM.

J Cell Biol. 1999 Nov 29;147(5):1063-72.


Activation of p53 function in carcinoma cells by the alpha6beta4 integrin.

Bachelder RE, Marchetti A, Falcioni R, Soddu S, Mercurio AM.

J Biol Chem. 1999 Jul 16;274(29):20733-7.


Postbinding functions of CD4 in HIV infection.

Bachelder RE, Letvin NL.

Trends Microbiol. 1996 Sep;4(9):359-63. Review.


Supplemental Content

Loading ...
Support Center